谷歌浏览器插件
订阅小程序
在清言上使用

PIER Trial: Neoadjuvant Therapy with Panitumumab (P) and Mfolfox-6 in an Enriched Population of Patients with T3 Rectal Adenocarcinoma of the Middle Third with Clear Mesorectal Fascia.

JOURNAL OF CLINICAL ONCOLOGY(2018)

引用 0|浏览79
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要